What is the primary purpose of the new $2.5 billion credit agreement?

The primary purpose of the Amended and Restated 5-Year Credit Agreement is to provide WellPoint, Inc. with significant financial flexibility for general corporate purposes, including financing acquisitions and managing working capital requirements. It also serves to replace the company's existing credit facilities.

What are the key provisions of the new Executive Severance Plan?

The Executive Severance Plan is designed to attract and retain key employees by offering severance pay and benefits upon involuntary termination, excluding death, disability, or 'cause.' It provides enhanced benefits upon termination within a specific period around a 'change in control' or for 'good reason' post-change in control. Severance includes salary continuation, bonus, benefits continuation, retirement plan contributions, and outplacement services.

Were there any significant changes in the company's leadership reported in this filing?

Yes, Leonard D. Schaeffer resigned as Chairman of the Board. Larry C. Glasscock was elected to succeed Mr. Schaeffer as Chairman of the Board, and he continues to hold his positions as President and Chief Executive Officer.

How does the company plan to use the new credit facility, and are there any limitations?

The credit facility is available for general corporate purposes, including acquisitions and working capital. The agreement includes customary covenants, such as limitations on incurring additional debt (total debt to capital ratio not to exceed 40%), engaging in affiliate transactions, changing corporate structure, and disposing of assets. It also outlines standard events of default and remedies.

ELV 8-K: Leadership Changes, Material Agreements & More

Summary

This 8-K filing from WellPoint, Inc. (now Elevance Health) on December 2, 2005, details significant corporate actions. Most notably, the company entered into an Amended and Restated 5-Year Credit Agreement for up to $2.5 billion, replacing previous credit facilities. This provides substantial liquidity for general corporate purposes, including potential acquisitions and working capital needs. Additionally, the filing announces the approval of the WellPoint, Inc. Executive Severance Plan, effective January 1, 2006. This plan is designed to attract and retain key executive talent by offering severance pay and benefits upon involuntary termination under specific conditions, including enhanced benefits tied to change-in-control events. The company also reported a change in leadership, with Larry C. Glasscock succeeding Leonard D. Schaeffer as Chairman of the Board, while retaining his roles as President and CEO. Finally, a bylaws amendment shifted responsibility for non-employee director compensation from the Compensation Committee to the Governance Committee.

Key Highlights

1WellPoint, Inc. secured a new $2.5 billion 5-Year Credit Agreement, replacing prior facilities, to support general corporate needs and potential acquisitions.
2The new credit facility includes a $200 million letter of credit sublimit and is guaranteed by Anthem Holding Corp.
3A new Executive Severance Plan was approved, effective January 1, 2006, aimed at retaining key executives by providing severance benefits upon involuntary termination.
4The severance plan offers enhanced benefits tied to change-in-control scenarios and "good reason" terminations.
5Leonard D. Schaeffer resigned as Chairman of the Board.
6Larry C. Glasscock was elected Chairman of the Board, consolidating his roles as President and CEO.
7The company confirmed its ability to meet previously stated earnings expectations during upcoming investor meetings.

Elevance Health, Inc. 8-K Report, Material Agreement (Dec 2, 2005)

Summary

Key Highlights

Frequently Asked Questions